Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Berruti

Showing results (21-30 of 379) with videos related to

Pageof 38
Sort By:
Current Opinion in Oncology|November 26, 2025
Oligometastatic adrenocortical carcinoma: definition and treatmentMarta Laganà, Alfredo Berruti, Salvatore Grisanti, et al.
Current Opinion in Oncology|October 20, 2021
Molecular genotyping of adrenocortical carcinoma: a systematic analysis of published literature 2019-2021Salvatore Grisanti, Deborah Cosentini, Sandra Sigala, et al.
European Urology|February 4, 2019
Higher Risk of Fragility Fractures in Prostate Cancer Patients Treated with Combined Radium-223 and Abiraterone: Prednisone May Be the CulpritAlberto Dalla Volta, Anna Maria Formenti, Alfredo Berruti
Annals of Translational Medicine|October 30, 2018
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practiceSalvatore Intagliata, Elisa Roca, Deborah Cosentini, et al.
Cancers|April 3, 2021
Adrenocortical CarcinomaAlfredo Berruti, Guido Alberto Massimo Tiberio, Sandra Sigala
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 2, 2025
Navigating Uncertainty in Adjuvant Mitotane TherapyMassimo Terzolo, Martin Fassnacht, Alfredo Berruti, et al.
European Urology Focus|July 21, 2017
Systemic Therapy in Locally Advanced or Metastatic Adrenal Cancers: A Critical Appraisal and Clinical Trial UpdateLaura Ferrari, Mélanie Claps, Salvatore Grisanti, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 12, 2026
Is the EDP-M regimen able to prolong survival in patients with metastatic adrenocortical carcinoma?Alfredo Berruti, Deborah Cosentini, Marta Laganà, et al.
Endocrine|December 19, 2023
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic toolG Mazziotti, A G Lania, Marta Laganà, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 10, 2018
Biological bases of radical prostatectomy in the management of prostate cancer patients with oligometastatic diseaseAlberto Dalla Volta, Alessandro Antonelli, Claudio Simeone, et al.
Pageof 38

Showing results (21-30 of 379) with videos related to

Sort By:
Pageof 38
Current Opinion in Oncology|November 26, 2025
Oligometastatic adrenocortical carcinoma: definition and treatmentMarta Laganà, Alfredo Berruti, Salvatore Grisanti, et al.
Current Opinion in Oncology|October 20, 2021
Molecular genotyping of adrenocortical carcinoma: a systematic analysis of published literature 2019-2021Salvatore Grisanti, Deborah Cosentini, Sandra Sigala, et al.
European Urology|February 4, 2019
Higher Risk of Fragility Fractures in Prostate Cancer Patients Treated with Combined Radium-223 and Abiraterone: Prednisone May Be the CulpritAlberto Dalla Volta, Anna Maria Formenti, Alfredo Berruti
Annals of Translational Medicine|October 30, 2018
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practiceSalvatore Intagliata, Elisa Roca, Deborah Cosentini, et al.
Cancers|April 3, 2021
Adrenocortical CarcinomaAlfredo Berruti, Guido Alberto Massimo Tiberio, Sandra Sigala
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 2, 2025
Navigating Uncertainty in Adjuvant Mitotane TherapyMassimo Terzolo, Martin Fassnacht, Alfredo Berruti, et al.
European Urology Focus|July 21, 2017
Systemic Therapy in Locally Advanced or Metastatic Adrenal Cancers: A Critical Appraisal and Clinical Trial UpdateLaura Ferrari, Mélanie Claps, Salvatore Grisanti, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 12, 2026
Is the EDP-M regimen able to prolong survival in patients with metastatic adrenocortical carcinoma?Alfredo Berruti, Deborah Cosentini, Marta Laganà, et al.
Endocrine|December 19, 2023
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic toolG Mazziotti, A G Lania, Marta Laganà, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 10, 2018
Biological bases of radical prostatectomy in the management of prostate cancer patients with oligometastatic diseaseAlberto Dalla Volta, Alessandro Antonelli, Claudio Simeone, et al.
Pageof 38